2020 News Highlights

Benfotiamine and Cognitive Decline in Alzheimer's Disease, a small exploratory clinical trial, conducted by Dr. Gary E. Gibson’s laboratory at the Burke Neurological Institute is listed in CNN Health’s article on ”Top 2020 health stories you may have missed because of Covid-19” under Advances in Alzheimer’s.

A small exploratory clinical trial conducted by Dr. Gary E. Gibson’s laboratory at the Burke Neurological Institute in collaboration with physicians at the Burke Rehabilitation Hospital, suggests that Benfotiamine is safe and potentially efficacious in improving cognitive outcomes among people living with Mild Cognitive Impairment and mild Alzheimer’s disease (AD).

On Wednesday, November 18, 2020, Dr. Dianna Willis spoke about life of a scientist to children of the Kliptown Youth Program in South Africa, an educational program that helps boost academic excellence among very disadvantaged children.

NEI-funded research is aimed at objectively evaluating what people living with low vision due to cerebral (cortical) visual impairment (CVI) can and cannot see, especially in situations where a significant intellectual disability interferes with the ability to communicate or read an eye chart.

May 6, 2020 – Featured on the cover of Cell Chemical Biology, a new and significant review article by Dr. Raj Ratan, Executive Director of the Burke Neurological Institute, examines “The Chemical Biology of Ferroptosis in the Central Nervous System.”

Johns Hopkins University announced with great honor to induct Dr. Raj R. Ratan, executive director of Burke Neurological Institute, into the John Hopkins Society of Scholars. Each year, the Society of Scholars Selection Committee elects a limited number of scholars, artists, and scientists who spent a portion of their careers at Johns Hopkins from among the candidates nominated by Johns Hopkins University faculty.